Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials

BACKGROUND: Diabetes is common in patients with rheumatoid arthritis (RA). Interleukin (IL)-6 is implicated in both the pathogenesis of RA and in glucose homeostasis; this post hoc analysis investigated the effects of IL-6 receptor vs. tumour necrosis factor inhibition on glycosylated haemoglobin (H...

Descripción completa

Detalles Bibliográficos
Autores principales: Genovese, Mark C., Burmester, Gerd R., Hagino, Owen, Thangavelu, Karthinathan, Iglesias-Rodriguez, Melitza, John, Gregory St, González-Gay, Miguel A., Mandrup-Poulsen, Thomas, Fleischmann, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488252/
https://www.ncbi.nlm.nih.gov/pubmed/32907617
http://dx.doi.org/10.1186/s13075-020-02229-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7488252/
https://www.ncbi.nlm.nih.gov/pubmed/32907617
http://dx.doi.org/10.1186/s13075-020-02229-5

Ejemplares similares